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Abstract
Objective: To analyze the need for increased content on genomics in Public Health (PH)
academic curriculum.
Methods: A literature synthesis was performed of various genetic science studies. Results were
assessed with regard to the number and type of genomic studies published, cost to perform
genetic analyses, health care provider and the public’s use and understanding of genetic testing
capabilities. A search was conducted and assessment performed of public health genomics
curriculum at accredited public health educational programs.
Results: The cost to sequence a single genome declined from $10 million in 2007 to under $10
thousand in 2012. This cost reduction correlates with an uptrend in published genome-wide
association studies from about 50 published in 2007 to over 1300 published in 2012.
Approximately 2000 genetic tests are currently available with applications relevant to
environmental genetics, personalized medicine and reproductive trait testing. A dearth of
genetics-related material in academic PH programs is juxtaposed against current advancements
in genetics.
Conclusions: Public health professionals should learn and develop genomic science materials
for health promotion and education and policy addressing today’s genetic determinants of health.
A broad-based PH genomics course which introduces many issues versus deep details into a
single genomics topic would address this need for the next generation of public health students
and would be a valuable continuing education offering for current professionals. The discussion
includes recommendations related to a full spectrum of PH programs, to include smaller
programs that may not be in a position to add a new focus of study.
Keywords: genetics, DNA, personalized medicine, pharmacogenomics, academia

NEEDS ASSESSMENT FOR PUBLIC HEALTH GENOMICS EDUCATION

5

Critical Analysis of Contemporary Public Health Genomics and Needs Assessment for
Public Health Genomics Course Curriculum
The National Human Genome Project and genetic science research is rapidly increasing a
variety of uses for human genetic information in medical treatment, environmental genetics
health risk assessments, and reproductive selection of viable embryos in fertility treatment. The
Centers for Disease Control and Prevention has therefore dedicated efforts aimed at increasing
activity and awareness in public health genomics (CDC, 2013). While some explorations in the
human genetic sciences are in their infancy, this very fact brings uncertainties and anxieties that
are already affecting human health in ways never before seen. For instance, a genetic test may
indicate that an individual is susceptible to a particular disease, but a conundrum arises as to
what to with this knowledge without symptomatic condition or proven treatment options. Equal
access to genetic tools is a concern that prevails in contemporary public health policy, parallel to
the concern about equal access to other medical services. Without equal access to genetic
services, social disparities in personal health, already a contemporary public health challenge,
will be exacerbated.
Reproductive genetic technology also poses new public health policy concerns as rapidly
advancing technology advances are used for reproductive gender selection and selection of nondiseased embryos for implantation. Broader application of these genetic technologies raise
societal implications related to increasing gender choice and imbalances in health prosperity,
which will compound existing public health challenges and could create new ones.
Environmental genomics is a related and compelling contemporary science that directly
impacts public health policy. The aim of environmental genomics is to develop predictable
correlation of response to environmental exposures by genetically susceptible persons. As this
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science develops, it will allow for more precise disease/health risk determination and thus more
targeted, less sweeping and less costly environmental health exposure regulations.
As genetic science capabilities continue to advance, guidelines for use of this information
need to be reflected in public health practice and serve medical treatment modalities.
Accordingly, public health professionals should be on the front lines of elucidating and
developing not only genomic science, but also the legal, ethical and social implications of
genetic determinants of health.
Healthy People 2020 (United States Department of Health and Human Services [DHHS],
2013) contains an objective area for genomics, which was not in Healthy People 2010. Under
the “Objectives” section of Healthy People 2020, several future opportunities of genomics in
public health are recognized. These opportunities include specifically “[I]ncorporating healthrelated genomics education in primary, secondary, undergraduate, and graduate curricula”
(DHHS, 2013, Emerging Issues in Genomics, line 7). This paper focuses on current graduate
curricula and demonstrates a dearth of public health genomics materials in these programs. An
introductory, broad topical public health genomics course (e.g., overview of many topics vs.
deep detail into any one) would help fill this need initially for newly developing public health
professionals and could be a valuable continuing education offering for established professionals.
Statement of Purpose
The purpose of this culminating experience manuscript is to determine whether public
health academic programs include adequate curriculum related to current human genetics
sciences. To this end, the manuscript will answer the following questions:
1. What is the state of genetic science at it relates to Public Health Genomics?
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2. Does contemporary Public Health Genomics demonstrate a need to include more
genomics-related material in standard Masters Public Health curricula?
3. What type of Public Health Genomics course would be useful to students’
professional development?
Methods
A literature review and synthesis was performed of genetics-related peer-reviewed
studies and other genetic science related professional source material. Studies and materials used
were obtained using key word searches of “genetics,” “genomics,” and “public health”.
Quantifying analysis was used to illustrate increases in the number and type of genomic studies
and decreases in cost to perform them. Prior survey research was assessed related to health care
providers’ use of genetics in clinical medicine and the public’s use and understanding of genetic
testing capabilities and results. An internet and literature search was conducted and critical
content assessment performed of public health genomics resources and programs at academic
public health programs in the United States. Findings were assessed with regard to applications
of genetics and public health and corresponding existence of public health course curriculum.
Literature Review
General Current Status of Genomic Science
Healthy People 2020 is the first Healthy People program to include genomics in its
targeted health outcomes. The goal is to “improve health and prevent harm through valid and
useful genomic tools in clinical and public health practice” (DHHS, 2013, Goal, paragraph 1).
Healthy People 2020 includes genomics because individuals’ genetics play a role in nine out of
ten leading causes of death, including heart disease, cancer, stroke, diabetes, and Alzheimer’s
disease (DHHS, 2013, Why Genomics is Important, paragraph 1). For example, studies show
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that women who have inherited a disease-causing mutation in the BRCA1 gene have a 55 to 65
percent risk of developing breast cancer by age 70, and women who have inherited a diseasecausing mutation in the BRCA2 gene have a 45 to 47 percent risk (Chen & Parmigiani, 2007;
Antoniou, Pharoah, & Narod, 2003). For women whose genetic tests reveal the gene mutations
for BRCA 1 and BRCA 2, breast surgery is an early intervention option that could reduce the
risk of breast cancer by 95 percent (Hartman et al., 1999; Domchek et al., 2010; Rebbeck,
Friebel, & Lynch, 2004; Meijers-Heijboer, Van Geel, &Van Putten, 2001).
The cost of genetic testing and the number of studies performed in recent years is
relevant to the topic of the current state of genomic science. Figure 1 shows the cost of genetic
sequencing since the completion of the Human Genome Project in 2003. The cost of genetic
testing has been in a downward spiral since about 2008 (National Institutes of Health [NIH],
2013a). Figure 1 shows two metrics related to the cost of DNA sequencing. The "Cost per
Megabase of DNA Sequence" is the cost of determining one megabase (Mb; a million bases) of
DNA sequence. The "Cost per Genome" is the cost of sequencing a human-sized genome. The
cost to sequence per human sized genome in 2007 was an estimated $10 million; in 2012 the
same test cost under $10 thousand.

8
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Figure 1. Cost of genetic synquencing trends.
Source: NIH, 2013b

The cost effectiveness of gene sequencing has been increasing over the last decade due to
advance in technology such as automation. Prior to 2008, first generation sequencing platforms
were used, and after 2008 new second generation sequencing platforms became available. These
advancements have been driven by a competitive market to reduce costs to the point where
genetic testing could be used in individual’s routine medical care (Shendure, Mitra, Varma, &
Church, 2004). Today, direct-to-consumer (DTC) genetic testing companies, such as 23andMe
(2013) provide personal genetic testing for $99.00 1. The orders for these tests are placed entirely
on-line at a computer with salivary DNA samples sent to the company via standard mail.
Figure 2 shows the total number of genome-wide research studies published from years
2004 to 2012. There is a notable upward trend beginning in 2008, the same year that the cost of
genetic testing began to substantially decrease. Literature suggests there is an association
between the decreased cost of genetic testing and the increase in genetics related studies. For
example, Rowell (2013) conducted a study to determine trends in pathogen genetics studies and
concluded that advances in technology have increased investigations into the role of human
1

Further review of DTC genetic testing is addressed later.
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genetic variation in the epidemiology of infectious diseases. Specifically, the study analyzed
human genome epidemiology articles published from 2001 to 2010 (n=3,730), which included
23 genome-wide association studies (GWAS). The number of published articles each year
increased from 148 in 2001 to 543 in 2010. Rowell (2013) concluded that as genomic research
methods become more affordable, population-based research on infectious diseases will expand
investigations into the role of variation in human genomes and bring new understanding of
infectious disease susceptibility, severity, treatment, control, and prevention.

Figure 2. Genome-wide research studies published 2004-2012.
Source: NIH, 2013b

Personalized Medicine
Personalized medicine is the use of genetic testing to advance diagnosis of, or
predictability for disease, and in turn provide earlier and individually tailored prevention and/or
treatment intervention. Such tests are of interest to physicians, researchers, and members of the
general public who are interested in better understanding their potential for developing specific
diseases. It is therefore important for public health professionals to understand the changing
landscape of tests available for this type of disease risk analysis.
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There are about 2,000 genetic tests currently available for clinical use in personalized
medicine efforts (CDC, 2013). However, Hamburg and Collins (2010) illustrates that there was
no single public source of comprehensive information about these tests and whether they were
cleared or approved by the United States Federal Drug Administration, which made it difficult
for clinicians and consumers to make informed decisions about the testing to optimize individual
health care. This problem was rectified on February 29, 2012, when the NIH started the Genetic
Testing Registry (GTR), a centralized online resource for information about genetic tests (NIH,
2012). The intended audience for the GTR is health care providers and researchers.
Genetests is a medical genetic information resource owned by BioReference Laboratories
created for physicians and geneticists that maintains a directory of laboratories offering genetic
testing (Genetests.org, 2012). The organization reports exponential growth in the number of
diseases tested for with molecular genetic testing. In 1993 there were approximately 100 clinics
that tested for about 100 diseases. In 2012, just over 600 laboratories offered tests for over 2,900
diseases.
Three ways for an individual in the United States to obtain genetic testing include: as a
patient from a clinical provider; as a research subject in a genetic research study; and, as a
private consumer through commercial genetic testing companies. Each of these testing methods
is reviewed below.
Clinical setting testing.
Despite the number of genetic tests increasingly available for clinical utility, studies
indicate that health care providers may not be prepared to appropriately offering genetic tests or
incorporating genetic testing in their clinical practice due to lack of familiarity or knowledge
(Harvey et al., 2007; Cox et al., 2012). Harvey et al. (2007) reported that of 5,915 survey
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respondents, 64% of patients with genetic conditions received no genetic information materials
from their provider. Five years later, Cox et al. (2012) randomly surveyed 2,191 cancer
providers in Oregon to determine genetic testing practices of these clinicians. Cox surveyed
providers about their use of ten types of genetic cancer tests. The survey included a description
of each genetic test and summary of the evidence-based recommendations published by the
Evaluation of Genomic Applications in Practice and Prevention (EGAPP), the U.S. Preventive
Services Task Force (USPSTF), and the National Comprehensive Cancer Network (NCCN).
The results illustrated a lack of familiarity with the genetic test as the most common reason why
clinicians did not order certain tests (Cox et al., 2012).
Genetic testing through research studies.
Various types of federally-funded genomic research studies are on-going in which
thousands of individuals across the nation are recruited to be volunteer human research
participants (National Human Genome Research Institute, 2013; Church, 2005; Coriell, 2011).
Standards for genetic research are implemented by the NIH’s Office of Human Research
Protections (OHRP). Nonetheless, due to the breadth and pace of genetic science advanced,
attendant future risks, clinical utility, and the full realm of ethical considerations are unknown
(NHGRI, 2013; Church, 2005). At a minimum, today’s genome testing is believed to carry the
following possible risks to individuals: Infer paternity or other features of the participant's
genealogy; possibility of statistical evidence that could affect employment or insurance or the
ability to obtain financial services for the participant; reveal relatedness to criminals or
incriminate relatives based on DNA samples used in forensic medicine; use of one’s synthetic
DNA at a crime scene; reveal propensity for a disease currently lacking effective treatment
options (Caulfield, 2008; McGuire & Beskow, 2010; Church, 2005).
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Direct-to-consumer testing.
Direct-to-consumer (DTC) genetic testing is commercial DNA testing that individuals
may obtain without medical provider involvement and without medical indication. The tests are
non-diagnostic and are marketed to provide insight to people about personal genetic traits and
risk of disease and ancestry (CDC, 2013). These genetic tests are marked on-line through
various DTC company websites. The customer provides a salivary DNA sample to the company
via regular mail. Examples of DTC companies are Navigenics (2013), 23andMe (2013) and
deCODEme (2013). Unlike DTC kits provided by the National Geographic Society (NGS)
(2013) and Ancestry.com (2013) that are designed primarily to inform about probably ancestral
groups, these companies offer genetic profile testing of hundreds of thousands of single
nucleotide polymorphisms to provide consumers their personal risk of developing various
disorders compared to the average population risk (Borry, 2010). Borry’s history of the
development of the DTC business sets forth that beginning in about 2007, advances in
technology lowered the cost of testing and in turn proliferated the number of genome-wide
association studies. However, there was little availability in the primary healthcare setting for
testing so private companies began to offer this service to customers commercially. Borry
(2010) reports that 2007 and 2008 saw a large number of DTC companies entered the market.
The author reported finding 12 for-profit Internet companies offering limited susceptibility
testing in 2003, and by 2009 there were over 30 companies offering some DTC services with a
few offering whole genome sequencing (Borry, 2010). The DTC business brings concerns for
potential consumers regarding credibility and comparability of tests, security of DNA use,
privacy of genetic risk information, and lack of confidence in non face-to-face genetic
counseling (Borry, 2010). Some DTC testing laboratories are voluntarily compliant with
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Clinical Laboratory Improvement Amendments (CLIA) that establishes quality standards for
laboratory testing (23andMe, 2013). However, there is no current Food and Drug Administration
regulation that standardizes testing and test results analysis at DTC companies. Thus the value
of the test results, in particular as they pertain to certain population sectors, remains uncertain
(CDC, 2013; Aehnbauer, 2011; Borry, 2010).
Disparities in genetic testing.
The literature suggests concern for differential access to and utilization of genetic testing
among racial and ethnic minorities compared to the majority white population, which may lead
to compounded health disparities (Hall & Olopade, 2006; Pagan, 2009; Zehnbauer, 2011). Hall
and Olopade (2006) report that genome testing research subjects come from a predominantly
European dissent; minority populations are therefore not well represented in genome reference
bio-repositories that form the basis for diagnostic genetic testing. 2 Zehnbauer’s (2011) report on
DTC companies showed that DTC companies’ interpretive associated risk reports are based upon
published scientific research correlating particular genetic variants with a specific disease or
condition; the majority of these peer-reviewed studies focused on Caucasian populations of
European ancestry. Thus, relevance of the interpretation of the genetic tests is questionable for
people of African, Asian, or Hispanic ancestry. Pagan (2009) analyzed a 2005 National Health
Interview Survey (n=25,364), and showed a lack of awareness of genetic testing for cancer
across racial and ethnic groups. Specifically, 48% of non-Hispanic whites reported that they
heard about cancer genetic testing, while only 31% of blacks, 28% of Asians, and 19% of
Hispanics were aware of genetic testing for cancer risk. Pagan concluded that culturally-tailored
approaches are needed to improve awareness amongst minority groups to avoid further disparity

2

Bio-repositories are reviewed on next page.
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in cancer screening and outcomes. This type of health education disparity falls well in the
domain of public health professionals.
Pharmacogenomics
Pharmacogenetics (PGx) is testing that analyzes a patient’s genetic make-up to determine
the best drug therapy for the particular patient based upon how they are expected to metabolize
certain medications (NIHGR, 2013). The use of PGx is meant to improve the safety and
effectiveness of drug therapies. Medco Health Solutions, Inc. and the American Medical
Association (AMA) conducted a nation-wide survey of 10,000 physicians (Medco Health
Solutions, Inc., 2009). Only 26% of the physicians reported any type of education in PGx and
less than half of them (10%) believed they had the necessary information and training to put PGx
testing to use in their clinical practice.
Bio-banks
In 2009 TIME magazine presented the “Top 10 Ideas Changing the World Right Now”
(Park, 2009). Bio-banks was listed as number eight. Bio-banks (or repositories) are a collection
of biospecimen samples often linked with individuals’ demographic and/or health information to
support a systematic approach to research. Biorepositories are not a new concept: skeletal
collections and organ/tissue banks are more traditional examples of this practice. However,
DNA bio-banks pose interesting research opportunities and ethical challenges as they are
increasingly used for the developing field of genetic research.
There are numerous DNA bio-banks supporting genetic studies in the United States. For
example, the Coriell Medical Institute Personalized Collaborative (CPMC) is a genetic study that
includes DNA banking to advance personalized medicine and PGx (Coriell Institute for Medical
Research, year). The CPMC study has 7,500 individual participants whose genetic data is linked
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to their full medical and family history in the CPMC DNA databank. These thousands of DNA
samples are banked for study purposes, and shared with other large DNA banks, such as NIH’s
Database of Genotypes and Phenotypes (dbGaP), a database at the National Center for
Biotechnology Information designed to archive and distribute coded genotype, phenotype,
exposure, and pedigree data from genome-wide association studies (DHHS, 2013). One of the
largest bio-banks currently is from the Personal Genome Project (PGP) started at Harvard
University (Church, 2005). This long-term project aims to sequence and publicize the complete
genomes and (anonymized) medical records of 100,000 volunteers in order to help advance
capabilities in personalized medicine.
Like other contemporary genetic banking studies, both CPMC and PGP are largely
conducted via communications between volunteers and researchers using computer and the
internet: this demonstrates how advances in technology drive larger databanks and make genetics
studies easier for scientists to conduct. These same advantages bring challenging implications in
data usage and access, data privacy and security and related implications. There remains no
federal statutory guidelines on genetic bio-banks with the failure of the 2006 Genomics and
Personalized Medicine Act (GovTrack, n.d.), which proposed to develop or expand populationbased bio-banks to study genetic factors that influence drug efficacy and to develop usage
guidelines for genetic bio-banks.
From the public health perspective, population-based bio-banking is a growing
consideration. State health departments have recognized opportunities to use population-based
bio-banks to be utilized to identify genes that contribute to human disease. For example,
Connecticut’s state health department’s Virtual Office of Genomics stated that the its
Departments of Public Health should be actively involved in public consultation and in
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development of related legislation and infrastructure needed to support population-based biobanks (Kelly, Stone, Manning, & Swede, 2007). Brand, Tobias, and Probst-Hensch (2012)
discuss the use of genome-based bio-banking for public health research, surveillance systems,
health policy development, individual health information management and effective health
services. They report that public health’s role with implications of research deriving from biobanks should include establishing an epidemiological research agenda, balancing individual and
social concerns, and promoting communication among genomics researchers, public health
agencies, policymakers, and the public.
Environmental genetics.
The environmental genetics field of practice is concerned with the interaction between
genes and the environment and the links to why some people get sick, while others do not
(OPHG, 2013). Thus, environmental genetics is the link between the environment and human
genes. Of the determinants of health, one’s genetics is the least controllable component.
However, there would be far reaching public health advantages to better predicting reactions to
environmental exposures via genetic testing.
For example, building on an earlier study by Kalada (2006) and Ritz (2009) reports that
pesticides plus certain human genetic types may increase risk of Parkinson's disease. This
dopamine transporter genetic variant study found that people with a single susceptible allele who
lived within 500 yards of fields where pesticides commonly used in agriculture 3 were used had
three times increased risk of developing Parkinson’s disease. People who had two or more
susceptible alleles had almost a 5-fold increase in risk. Ritz noted that people who were
genetically susceptible but had no pesticide exposure showed no increased risk of Parkinson’s.
The study results suggested that individuals with a particular genetic make-up may be singularly
3

The specific pesticides named in the study are maneb and paraquat.
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sensitive to the neurodegenerative effects of certain pesticides; these findings could have
implications for residents of agricultural communities as well as farm workers or industrial
works in plants that produce these pesticides.
Environmental health genetics emerged as a viable public health research area in the late
1990s. Kelada (2006) reported a list of seventeen proposed genetic effect modifiers of common
exposures, which he concludes is suggestive of promising actionable findings with further
research in these areas. Table 1 shows various studies that specifically assessed particular
genotype interactions with pesticide exposures. All but one of these studies took place after the
costs of genetic sequences began to decline in 2004, further evidence of the association between
reduced cost of genetic sequence testing and increase in number of genetic studies. With the
advances in genome-wide sequencing beginning in 2003, environmental health genetics has
become more prominent in public health research. As the numbers and types of environmental
health studies continue to grow, chronic decease may be better prevented in genetically high-risk
populations.
Table 1.
Environmental Genetics Studies Pertaining to Pesticides and Genetic Type
Genotype Type
ABCB1
MM PON1-55

Exposure
Organochlorine insecticides
Diazinon and Chlorpyrifos
Paraquat and Maneb

P450 2D6
MnSOD
NQ01
Combined MnSOD/NQO1

Pesticides
Pesticides
Pesticides
Pesticides
Paraquat and Maneb
Pesticides

CYP 2D6 29B+ allele

Study
Dutheil et al., 2010
Manthripragada et al., 2010
Ritz et al., 2009 confirming
Kelada, 2006
Elbaz et al., 2007
Fong et al., 2007
Fong et al., 2007
Fong et al., 2007
Kelada et al., 2006
Hubble, 1998

With the increasing development of environmental health genetics science, there are
several related public health policy considerations. Resnik (2005) has identified several
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developing policy areas related to public health genetics. They include: Should public health
departments offer genetic tests? Should genetic tests only be offered to those in known
environmentally risky areas? Should public health warn the public when predictive tests do
evolve? Should product industry warn the public of possible genetic risks linked to their
product? Should genetic tests be mandated for vulnerable groups, such as children? Should
products be regulated differently regarding genetic links? Environmental genetics is a
developing science with many major public health implications.
Reproductive genetic uses.
Preimplantation genetic diagnosis (PGD) is a means of detecting genetic disorders prior
to an embryo being implanted (CDC, 2007). A single cell is biopsied from the embryos and
tested before they are implanted. This allows for selection or de-selection of certain embryos
prior to establishing pregnancy. PGD permits detection of genetic abnormalities and detection of
certain early and late onset diseases. Thus, PGD helps reduce the number of newborns with or
susceptible to specific genetic diseases, and avoids many issues related to considerations for
termination of pregnancy in the later prenatal screening stages. However, PGD also allows for
determination of other non-medical traits, such as gender, which introduces additional ethical
considerations.
PGD is used by some to choose the sex of the embryo to be implanted as a means of
family balancing. Generally, the use of PGD for testing of non-medical traits is controversial.
Some countries that allow PGD also have legislature concerning PGD that prohibits sex selection
(Viville & Pergament, 1998; Wells & Delhanty, 2001; Hudson, 2006; Baruch, 2008a). However,
the United States permits non-medical PGD sex selection. There are no federal or state laws that
directly regulate PGD for sex selection and professional guidelines, such as from the American
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Society for Reproductive Medicine, are not binding (Deeney, 2013, p. 340). This leaves fertility
clinics to devise their own policies on PGD. According to Hudson (2006) a 2004 survey study of
almost five thousand Americans showed that nearly 50% of women and 35% of men approved of
PGD testing for sex selection (p. 1642). Sidhu (2012) reported that $18,000 was the average cost
of a gender selection procedure at high-profile clinics with an estimated 4,000 to 6,000
procedures performed every year. “Fertility doctors foresee an explosion in sex-selection
procedures on the horizon, as couples become accustomed to the idea that they can pay to beget
children of the gender they prefer” (Sidhu, 2012, p.1).
A 2006 survey of 415 assisted reproductive technology (ART) clinics in the United
States, showed that 93% of ART clinics that offered in-vitro fertilization (IVF clinics) provided
PGD services to patients and 42% of these provided PGD for sex-selection in addition to healthrelated diagnosis (Baruch, 2008a). Baruch (2008a) concluded that PGD is widely provided by a
large majority of United States IVF clinics, including PGD for sex selection.
Two other studies obtained direct data from IVF clinics pertaining to PGD outcomes for
non-medical sex selection. Gleicherh and Barad (2007) obtained data from an IVF clinic in New
York of 92 couples using PGD for family balancing between the years 2004-2006. A total of 56
male vs. 36 female embryos were selected for implantation. This study also included ethnicity
and showed significantly higher male preference in Chinese, Arab/Muslim, and Asian-Indian,
and for Western ethnicities a slight, but non-significant, preference for females. Finally, Colls
(2009) obtained survey data from 246 clinics across the United States and found similar results
with 127 male vs. 119 female embryos selected. Again, significant preferences for males were
found in Chinese and Indian subjects, while a preference for females was found in Western
subjects.

NEEDS ASSESSMENT FOR PUBLIC HEALTH GENOMICS EDUCATION

21

Related to reproduction and genetics, newborn genetic testing may become another area
soon to be impacted by advancements in genetic science. The National Institutes of Health
(NIH) recently published a news release stating that $25 million dollars would be spent over the
next five years in the Genomic Sequencing and Newborn Screening Disorders research program
to explore possibilities of sequencing newborns’ genomes. The goal is to determine whether
useful medical information could be obtained by genetic testing beyond current newborn
screening standards (National Institutes of Health [NIH], 2013c).
Assessment of Genomics in Public Health Education
Genomics in academia/public health education.
A Healthy People 2020 goal related to genomics recognizes several future opportunities
of genomics in public health. Among these is: “[I]ncorporating health-related genomics
education in primary, secondary, undergraduate, and graduate curricula” (DHHS, 2013, line 7).
In 1997, the CDC established the Office of Public Health Genomics (OPHG) that
promotes the integration of genomics into public health research, policy, and practice (see
www.cdc.gov/genomics). According to the OPHG, scientific developments over recent years
have resulted in new potential for health impact. The 2011 OPHG Stakeholder Consultation
Priorities Conference Report identifies advancing education in the public health profession
regarding genomics as one of the 5 year priority items for 2012-2017 (Office of Public Health
Genomics [OPHG], 2011, p. 17). The report found that there needs to be “a greater
understanding by public health professionals of what genome-based knowledge can bring to
public health practice” (p. 42). The report specifically recommends: “Incorporate genomics into
the curricula of medical schools, nursing schools, and schools of public health” (p. 42). Thus, in
2012 OPHG developed five-year priorities for public health genomics as well as a specific action
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plan for genomic implementation in public health practice (CDC, Public Health Genomics 2013
at a Glance, Section 1, n.d.).
In 2003 the Institute of Medicine (IOM) recommended that genetics be added as a new
content area to be covered by every school of public health. This recommendation was made
based upon IOM’s assessment of the broader applications possible within public health of
genomics versus previous genetic science aimed only at individuals. Recent personal
correspondence with the three editors of the 2003 IOM report indicates the document has not
been updated to determine whether and how the recommendations have been implemented (K.
Gebbie, personal communication, 28 Oct. 2013; Rosenstock, 2013; L. Hernandez, personal
communication, 28 Oct. 2013). Enough time has passed to make these assessments.
In 2007 the NIH’s Secretary’s Advisory Committee, Genetics, Health and Science
(SACGHS) reported that there were 38 schools of public health in the United States that offered
courses related to genetics or genomics. Of the 38 public schools, 11 had centers with
concentrations in genetics or public health genomics and thus had several genetics and genomics
related courses at these centers. The other 27 were general public health programs that offered
one or two genetics related courses.
The literature review for this paper found no surveys or other data reporting the extent to
which U.S. public health programs have incorporated genetics or genomics related courses since
2007. The Council on Linkages between Public Health Academia and Practice (housed as the
Public Health Foundation) and the Association of Schools and Programs in Public Health
(ASPPH) are two current organizations whose mission interests include public health core
competencies and education of public health professionals. A search of these organizations’
websites and published materials revealed no surveys of graduate public health education courses
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related to genetics courses. In support of this paper, each of these organizations was asked to
confirm whether they have conducted surveys of public health programs to obtain current data on
how many programs offer genetics or genomics related courses and to what extent. The Council
of Linkages did not respond. ASPHH responded that they have not and are not aware of any
such data (Wiest, personal communication, 2013).
The Council on Education for Public Health (CEPH) is an independent agency
recognized by the U.S. Department of Education to accredit schools of public health and public
health programs outside schools of public health. On its website, CEPH (n.d.) lists the names of
100 of its certified public health programs. During this review, a random selection of twenty of
the listed public health programs was analyzed for content regarding offering of genetics or
genomics related courses. The twenty public health program 2013 curriculums were obtained
from the respective programs’ websites. Full course catalogs were not reviewed for alternate
year courses were not accounted for in this review. A search of the 2013 course calendar was
done for any course within the program that used the word “genetics” or “genomics” in the
course title.
Table 2 shows the results of the program and curricula review. Of the twenty programs,
none had a concentration in genetics or genomics and none had required courses in the area of
genetics or genomics. Four of the ten offered one or two elective courses related to genetics or
genomics: University of Maryland at Baltimore, University of Cincinnati, Oregon Health and
Science University, and, New Mexico State University. While this assessment is not
representative, it does provide some idea of the lack of genetic content in public health curricula.
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Twenty CEPH-accredited Public Health Programs and their Genetics or Genomics-related Courses
Brown University
Providence, RI
East Carolina University
Greenville, NC
Eastern Kentucky University
Richmond, KY
Emory University
Atlanta, GA
Jackson State University
Jackson, MS
Morgan State University
Baltimore, MD
New Mexico State University
MPH Program in Community
Health Education
Las Cruces, NM

No mention of genetics or genomics in list of courses

Northwestern Ohio Consortium for
PH
Toledo, OH
Oregon State University
Portland, OR
St. George’s University
Great River, NY
San Diego State University
San Diego, CA

Genetic Epidemiology or Molecular Epidemiology

Temple University
Philadelphia, PA
University of Cincinnati Public
Health Program
Cincinnati, OH
University of Florida
Gainesville, FL
University of Iowa
Iowa City, IA
University of Kansas
Kansas City, KS
University of Maryland at
Baltimore MPH Program Baltimore,
MD
University of West Florida
Pensacola, FL
University of Wisconsin-Madison
Madison, WI
Virginia Tech
Blacksburg, VA

No mention of genetics or genomics in listed courses

No mention of genetics or genomics in list of courses
No mention of genetics or genomics in list of courses
EH527 Biomarkers and Environmental Public Health
No mention of genetics or genomics in list of courses
No mention of genetics or genomics in list of courses
GERO 456. Biological Aspects of Aging. Aging, the developmental
process of the body determined by cellular changes influenced by
lifestyle, genetics, and environment. Investigates these changes, how
health promotion influences them, and when they are considered a
disease.

PHPM 507 Genomics and Public Health: Current Issues and Future
Trends in Healthcare and Policy
No mention of genetics or genomics in listed courses
No mention of genetics or genomics in listed courses

PH 7064: Statistical Genetics (2013)
PH 8056: Environmental Genetics and Molecular Toxicology
No mention of genetics or genomics in listed courses
EPID5560 Introduction to Molecular Epidemiology
EPID 5570 Genetics and Epidemiology
No mention of genetics or genomics in list of courses
PREV 711, Genetic Epidemiology

No mention of genetics or genomics in list of courses
No mention of genetics or genomics in list of courses
No mention of genetics or genomics in list of courses
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Discussion
The completion of the National Human Genome Project, current advances in genetic
testing technologies and the proliferation of scientific research are rapidly increasing the uses of
human genetic information in medical treatment, reproductive applications, environmental
genetics and genomics, as well as personal use of genetic testing through commercial enterprise.
Because each of these areas has implications in public health, public health professionals should
have working knowledge of this science and its implications. As indicated in the 2011 IOM
recommendations, this knowledge should be made available in public health education programs.
Published genetic studies have exponentially increased since 2007 while the cost of
genetic tests decreased. The association between the lowering cost of genetic testing and
increase in published studies is reflected in the literature (Rowell, 2013; Borry, 2010; NIH,
2012). Consequently, genome-wide sequencing studies are being published and attendant data
placed in evolving national genetic bio-repositories to more quickly standardize and advance
genetic science. Resulting applications and opportunities are reflected in the literature.
Examples are Rowell’s (2013) report of expansions in infectious disease investigations, Borry’s
(2010) report of proliferation of consumer use of DTC testing, Ritz’s (2009) report of
environmental genomics applications, and documentation of increasing uses of genetic testing in
reproduction (Hudson, 2006; Baruch, 2008b; Colls, 2009).
There is no indication that the trend of continued reduced cost, increases in research, and
expanded use and commercializing of genetic testing is going to end. If this trend continues,
genetics and genomics will change modern day medicine and broaden implications to public
health.
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With 2,000 (and counting) clinically relevant genetic tests available to clinicians,
personalized medicine and pharmacogenomics have profound potential to prevent chronic
disease, to save life, and to extend life expectancy—all of which are direct public health
considerations (CDC, 2013). Early detection and intervention capabilities resulting from genetic
tests could significantly improve success in preventive medicine, as was demonstrated in the
BRCA 1 and BRCA 2 gene mutation, where multiple studies reported significant risk reduction
for breast cancer (Hartman et al., 1999; Domchek et al., 2010; Rebbeck et al., 2004; MeijersHeijboer et al., 2001).
Public health concerns related to personalized medicine include not only ensuring fair
and affordable access to genetic testing, but also protection from possible harms of testing. The
OPHG website offers public health community awareness initiatives that could help inform
people about these risks, which may include: depression, anxiety, guilt, family tension, false
sense of security, unclear results, costly testing and follow-up counseling (American Society of
Clinical Oncology, 2012).
Cost of disease treatment after onset is a contemporary public health challenge that could
be mitigated by genetics. It stands to reason the results of personalized medicine through
genetics and pharmacogenomics would decrease cost of medical care by better targeting
preventative treatments. Early detection and preventive treatment will result in fewer expressed
diseases and disease sequelae. Tailored prescriptions can mean less trial and error with drugs,
and thus less cost in pharmaceuticals.
The literature review in this paper supports Burke’s six recommendations for the role of
public health genomics in the “era of personalized medicine,” for public health involvement in
improving global human health through genomics:
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1) Continue to integrate genomics into public health research and practice;
2) Establish and maintain appropriate research infrastructure for generating an evidencebase for genomic medicine;
3) Develop, implement, and evaluate model public health genomics programs and clinical
services;
4) Promote international collaboration;
5) Foster appropriate genetic services and genome-based research;
6) Inform programs, research, and strategies in public health genomics by accepted
ethical principles and practices (each cited verbatim from Burke et al., 2010, p. 789).
It is not possible for public health professionals to fulfill these roles if they are not properly
educated in genomics and the public health applications.
Environmental genomics is a compelling contemporary science that directly impacts
public health because its very aim is to develop predictable correlation of environmental
exposures to genetically susceptible persons in order to allow for more precise risk determination
and thus more precise (better targeted, less sweeping and less costly) environmental health
exposure regulations. Rowell’s 2013 study determined that trends in pathogen genetic studies
revealing more knowledge about the role of human genetic variation in the epidemiology of
infectious diseases. Kelada’s (2006) and Ritz’s (2009) findings related to exposures to pesticide
linked to Parkinson’s disease demonstrate the promise of future actionable preventative health
potentials in environmental genomics applications. Kelada (2006) makes the case that more
epidemiological studies are warranted to advance this science. If public health students are
exposed early in their academic studies to this area of science, new epidemiologists may be more
compelled to incorporate genetics into contemporary study designs. As genetic capabilities
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continue to advance, it is imperative that guidelines for use of this information be reflected in
public health practice. If science and related regulations are to advance, the public health work
force must be educated in environmental genetics.
Reproductive genetic technology poses new significant public health policy concerns as
technology is used for non-medical treatment purposes such as reproductive gender selection and
selection of non-diseased embryos for implantation among those who can afford it. PGD for sex
selection may be a valuable choice for family balancing, but is wrought with ethical implications
yet to be resolved. Broader application of these genetic technologies may bring societal
implications such as increasing gender choice and health imbalances, all of which will compound
existing public health challenges and lead to new ones.
Contemporary genetic science brings public health issues related to equal access to
genetic testing and genetic health awareness disparities. Without equal access to genetic
services, social disparities in personal health, already a contemporary public health challenge
will be exacerbated. The Secretary’s Advisory Committee on Genetics, Health, and Society
(SACGHS) identified public genetics education as an important priority for public health
professionals and recommends improvements in education related to genetics and genomics
literacy (SACGHS, 2013). The literature review herein revealed areas where public health
professionals should be concerned about growing disparities. Table 3 shows a compilation of
areas where educated public health professionals could work to mitigate genetics and genomics
related disparities. These areas include environmental and epidemiological research, public
education on direct-to-consumer genetic services, facilitation of regulatory advancements on
public accessibility to reproductive testing involving genetics, and developing and implementing
culturally tailored awareness approaches related to genetics.
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Table 3
Areas of Public Health Disparities Related to Genomics
Research

Direct-to-Consumer Service

Reproductive Testing

Awareness

Primarily uses white population as subjects. Results in lack of validity for
clinical treatment, disease risk assessment, and environmental genomics
applications across racial and ethnic groups. Mitigation: Educate
epidemiologists and other genetic researchers to include subjects across
racial and ethnic groups. Educate public health policy practitioners to
implement and enforce research policy of fairness of representation in
publically funded research.
Socio-economic challenged may not afford the luxury of purchasing genetic
tests commercially. Mitigation: Educate public health policy practitioners
to implement fair public access to obtain genetic testing.
Elective IVF services are expensive and not covered by medical
insurance/welfare insurance. Socio-economic status will result in
disparities of those obtaining reproductive testing for diseased embryos
and/or trait selection. Mitigation: Educate public health policy practitioners
to implement fair access regulations and usage of genetic reproductive
technology.
Nearly 50% of whites have heard of genetic testing, while 33% or lower of
other racial and ethnic groups have not (Pegan, 2009). Lack of awareness
among minority populations may lead to compounded health disparities.
Mitigation: Educate public health community awareness practitioners about
culturally tailored awareness approaches related to genetics.

Discussion of Genomics in Public Health Education
Professional organizations and national health agencies have repeatedly documented the
needed to incorporate genetics and genomics in health education--not only medical and nursing
education, but also public health academic education. The literature review provides ample
documentation of leading national health organizations (NIH, IOM, CDC) that have determined
it imperative for genetics to be included in public health academia. IOM’s recommendation to
include genomics in public health academia was published in 2003, yet it appears public health
genetics related courses are still lacking from CEPH-accredited general public health graduate
programs.
Studies support the need for increased genetics education amongst health professionals.
Of 10,000 physicians surveyed nation-wide, only 26% of the physicians reported any type of
education in pharmacogenetics and only 10% of physicians believed they had the necessary
information and training to put pharmacogenetic testing to use in their clinical practice (Medco
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Health Solutions, Inc., 2009). Over 60% of nearly 6,000 cancer patients surveyed were not
provided genetic testing information from their providers (Harvey et al., 2007). As recently as
2012, 2,191 cancer doctors surveyed in Oregon did not perform validated/recommended cancerrelated genetic tests for patients because they lacked familiarity with the tests themselves (Cox et
al., 2012).
A barrier to including genetics in public health core curriculum may very well be
crowded program curriculum in which genetics competes with other more obvious, well-known
and popular public health concerns. Nonetheless, professional literature and studies repeatedly
demonstrate the lack of genetics in public health education and recommend better inclusion of
genetics in public health education to fight leading chronic diseases with genetic components and
to prepare future public health professions for the advanced world of the genetic era.
Suggested Methods to Incorporate Genomics in Public Health Education
In order to assess the exact need today regarding gaps of genetics courses in public health
programs, a comprehensive survey needs to be conducted to more precisely determine the extent
to which today’s public health students are exposed to genetics and genomics and related public
health implications. From these data, public health must develop and incorporate additional
genomics course material to fill the identified gaps in educational opportunities.
One method to influence inclusion of genetics and genomics material in public health
academic programs is to clearly include genomics within core competencies for public health
professionals. Academic programs are geared toward ensuring students are able to perform
public health core competencies. If such core competencies include genomics, this in turn would
motivate schools with public health programs to include more genomics materials in courses to
better prepare students to fulfill the core competencies related to genomics.
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A method to incorporate genetics and genomics material in the case of crowded public
health curricula, would be to ensure relevant modules are included in existing core courses. The
course title survey included in this article did not look at all material/modules within the courses
offered, so some may already have inclusions related to genetics. A fuller survey of academic
programs will solidify this. There are several possible ways to incorporate genetics in existing
curricula because genetics and genomics relate to multiple aspects of traditional public health
courses.
For instance, public health communication education and awareness courses could
include methods of communicating awareness of complex and ever-evolving issues related to
genetics. The health communication and awareness education should include aspects of
disparities related to genetic research subjects and public genetic literacy and awareness of
genetic testing across cultural lines. Public health professionals in the area of community
education and awareness and global health are well positioned to advance awareness of
genomics, decrease disparities, and increase appropriate genomic services that would save lives
today (OPHG, 2013).
Another example is epidemiology courses could better serve future public health
professionals if they included information about genome-wide association studies, the inclusion
(or lack thereof) of minorities in such studies, and the Genetic Testing Registry (GTR) (the
centralized online resource for information about genetic tests.) The intended audience for the
GTR is health care providers and researchers (NIH, 2013d). Epidemiology courses are also a
logical place to educate students about environmental genomics and inclusion of genetics in
environmental health population studies. The new world of bio-repositories and populationbased bio-banks is also ripe for inclusion in epidemiology education. Brand and colleagues
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(2012) make a compelling case for use of genome-based biobanking for public health research
and surveillance systems. Epidemiology students should learn that epidemiologists are in a good
position to include genetics components in their research that can further advance the modern era
of genomics for the betterment of public health.
Public health law, policy, management, and ethics courses could incorporate a plethora of
genetic and genomics related materials to better educate students. Courses should educate
students that public health professionals can and should be on the front lines of exploring and
developing legal, ethical, and social implications of the genetic determinant of health and
establishment of related policy. Policy education topics for genetics derived from the literature
for this paper include: Fair access policy and services for genetic testing; environmental
genomics regulation; ethical and legal standards for bio-repositories and use of genetic
information; development of standards for genetic testing and analysis of test results, in
particular from direct-to-consumer laboratories providing tests directly to the public without
medical consultation; regulating use of pre-implantation genetic testing, in particular for late
onset disease and trait testing.
Despite the value and need to include genetics in public health curriculum, the reality is
that there are different types, sizes and levels of public health certificate and degree programs in
the United States. Inclusion of additional material in the curriculum may be more challenging
for smaller programs. Small public health education programs may not have the capacity to
include more education material, let alone embark on courses on genomics or full concentrations
on genomics. For these smaller programs, aspects of genomics could be incorporated into
existing basic, required public health courses where appropriate. For instance, public health
introduction courses could include a survey chapter on various aspects of public health
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genomics. Environmental health courses could include more dedicated aspects of genomics and
gene-environment interactions. Epidemiology courses and Global Health courses could include
a lesson on genome-wide sequencing, the evolution of this science, and possible disparities of
representative populations in epidemiological genetic studies. Health Communication and
Awareness courses could include a chapter on the unique complexities of public health literacy
regarding genetics and genomics, due partially to the quickly evolving/changing science. Public
health law and policy basic courses could include a class on unique issues related to public health
genomics evolving policy. Existing faculty need not have advanced knowledge in the area in
order to ensure students are exposed to accurate public health genomics material. Instead, each
of these classes could highlight the genomics related material by having an expert guest speaker
in the genomics area discuss the topics in class.
Not all students need become public health genomics professionals, but all public health
professionals and graduating students of public health programs should have a basic working
understanding of the genetic sciences, today’s applications, and future opportunities for
genomics to improve public health. This basic professional competence could be obtained with
some level of genomics material incorporated in all public health education programs.
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Appendix - List of Competencies Met in CE
Tier 1 Core Public Health Competencies
Domain #1: Analytic/Assessment
Describe the characteristics of a population-based health problem (e.g., equity, social
determinants, environment)
Use methods and instruments for collecting valid and reliable quantitative and qualitative data
Identify sources of public health data and information
Identify gaps in data sources
Adhere to ethical principles in the collection, maintenance, use, and dissemination of data and
information
Domain #2: Policy Development and Program Planning
Gather information relevant to specific public health policy issues
Describe how policy options can influence public health programs
Gather information that will inform policy decisions (e.g., health, fiscal, administrative, legal,
ethical, social, political)
Domain #3: Communication
Identify the health literacy of populations served
Communicate in writing and orally, in person, and through electronic means, with linguistic and
cultural proficiency
Participate in the development of demographic, statistical, programmatic and scientific
presentations
Domain #4: Cultural Competency
Recognize the role of cultural, social, and behavioral factors in the accessibility, availability,
acceptability and delivery of public health services
Domain #5: Community Dimensions of Practice
Identify stakeholders
Describe the role of governmental and non-governmental organizations in the delivery of
community health services
Inform the public about policies, programs, and resources
Domain #6:Public Health Sciences
Identify the basic public health sciences (including, but not limited to biostatistics, epidemiology,
environmental health sciences, health services administration, and social and behavioral health
sciences)
Describe the scientific evidence related to a public health issue, concern, or, intervention
Retrieve scientific evidence from a variety of text and electronic sources
Discuss the limitations of research findings (e.g., limitations of data sources, importance of
observations and interrelationships)
Partner with other public health professionals in building the scientific base of public health
Domain #7: Financial Planning and Management
N/A
Domain #8: Leadership and Systems Thinking
Describe how public health operates within a larger system
Identify internal and external problems that may affect the delivery of Essential Public Health
Services
Participate in mentoring and peer review or coaching opportunities
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Concentration Competencies
Health Promotion and Education:
Area 1: Assess Needs, Assets and Capacity for Health Education
1.2 Engage stakeholders to participate in the assessment process
Area 2: Plan Health Education Programs
2.2 Select planning model(s) for health education
2.4 Formulate specific, measurable, attainable, realistic, and time-sensitive objectives
2.7 Organize health education into a logical sequence
Area 3: Implement Health Education
3.1 Identify training needs
3.2 Develop training objectives
Area 4: Conduct Evaluation and Research Related to Health Education
4.9 Disseminate research findings through professional conference presentations
Area 5: Manage Health Education Programs – N/A
Area 6: Serve as a health education resource person
6.6 Develop training plan
6.8 Use a variety of resources and strategies
6.10 Provide expert assistance
6.11 Evaluate the effectiveness of the expert assistance provided
Area 7: Communicate and advocate for health and health education
7.1 Lead advocacy initiatives
7.4 Use evidence-based research to develop policies to promote health
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